An atlas of active enhancers across human cell types and tissues
Open accessThe DOI matches its Crossref record; 80 of the 81 references it cites were found in a registry or an index.
Abstract
Enhancers control the correct temporal and cell-type-specific activation of gene expression in multicellular eukaryotes. Knowing their properties, regulatory activity and targets is crucial to understand the regulation of differentiation and homeostasis. Here we use the FANTOM5 panel of samples, covering the majority of human tissues and cell types, to produce an atlas of active, in vivo-transcribed enhancers. We show that enhancers share properties with CpG-poor messenger RNA promoters but produce bidirectional, exosome-sensitive, relatively short unspliced RNAs, the generation of which is strongly related to enhancer activity. The atlas is used to compare regulatory programs between different cells at unprecedented depth, to identify disease-associated regulatory single nucleotide polymorphisms, and to classify cell-type-specific and ubiquitous enhancers. We further explore the utility of enhancer redundancy, which explains gene expression strength rather than expression patterns. The online FANTOM5 enhancer atlas represents a unique resource for studies on cell-type-specific enhancers and gene regulation. Using the FANTOM5 CAGE expression atlas, the authors show that bidirectional capped RNAs are a signature feature of active enhancers and identify over 40,000 enhancer candidates from over 800 human cell and tissue samples across the whole human body. FANTOM5 (standing for functional annotation of the mammalian genome 5) is the fifth major stage of a major international collaboration that aims to dissect the transcriptional regulatory networks that define every human cell type. Two Articles in this issue of Nature present some of the project's latest results. The first paper uses the FANTOM5 panel of tissue and primary cell samples to define an atlas of active, in vivo bidirectionally transcribed enhancers across the human body. These authors show that bidirectional capped RNAs are a signature feature of active enhancers and identify more than 40,000 enhancer candidates from over 800 human cell and tissue samples. The enhancer atlas is used to compare regulatory programs between different cell types and identify disease-associated regulatory SNPs, and will be a resource for studies on cell-type-specific enhancers. In the second paper, single-molecule sequencing is used to map human and mouse transcription start sites and their usage in a panel of distinct human and mouse primary cells, cell lines and tissues to produce the most comprehensive mammalian gene expression atlas to date. The data provide a plethora of insights into open reading frames and promoters across different cell types in addition to valuable annotation of mammalian cell-type-specific transcriptomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although enriched, histone modification and cofactor binding is not completely predictive of enhancer activity54,58,72,77,105.”
From Towards a comprehensive catalogue of validated and target-linked human enhancers (2020) · cites this paper as [58]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The majority of active enhancers are themselves transcribed, producing enhancer RNAs (eRNAs) in a bi-directional manner [73–77].”
From Transcriptional enhancers and their communication with gene promoters (2021) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“In terms of their sequence properties, enhancers and promoters tend to differ in GC content, with many promoters and only a subset of enhancers containing CpG islands [74, 249].”
From Transcriptional enhancers and their communication with gene promoters (2021) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“We filtered intragenic CAGE TCs with GG-initiation and those overlapping with coding exons and annotated enhancers24,70”
From Alternative promoters in CpG depleted regions are prevalently associated with epigenetic misregulation of liver cancer transcriptomes (2023) · cites this paper as [24]
In the citing paper
“as regulatory elements are subject to positive selection pressure, we identified sequences showing the highest conservation across mammalian species, including humans25–29.”
From Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans (2020) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364 · cited 1×
“These were grouped according to Hela-S3 expression tertiles: low (36), mid-level (41) and strong (46).”
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Regularization Paths for Generalized Linear Models via Coordinate Descent
Friedman, J., Hastie, T., & Tibshirani, R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i01 · Cited by 19,927
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382 · cited 1×
“These were grouped according to Hela-S3 expression tertiles: low (36), mid-level (41) and strong (46).”
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
Cited by
Items 801–900 of 1,017
Hisano, O., Ito, T., & Miura, F. (2021) · BMC Biology · doi:10.1186/s12915-021-01160-8 · Cited by 38
“We performed the same enrichment analysis on the enhancers annotated by the FANTOM5 project (Andersson et al. 2014; Lizio et al. 2019) and found that the frequency of appearance of C3D peaks was 2.8 times higher than expected in these enhancers (Supplementary Figure S7D).”
MethodInfluentialExploring noncoding variants in genetic diseases: from detection to functional insights
Wu, K., Bu, F., Wu, Y., Zhang, G., Wang, X., He, S., Liu, M., Chen, R., & Yuan, H. (2024) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2024.01.001 · Cited by 41
Long-range evolutionary constraints reveal cis-regulatory interactions on the human X chromosome
Naville, M., Ishibashi, M., Ferg, M., Bengani, H., Rinkwitz, S., Krecsmarik, M., Hawkins, T. A., Wilson, S. W., Manning, E., Chilamakuri, C. S. R., et al. (2015) · Nature Communications · doi:10.1038/ncomms7904 · Cited by 41
Dissecting the nascent human transcriptome by analysing the RNA content of transcription factories
Caudron‐Herger, M., Cook, P. R., Rippe, K., & Papantonis, A. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv390 · Cited by 40
“…many other non-protein-coding RNAs have been uncovered (2,3) including micro-RNAs (miRNAs)(4), long inter-genic non-coding RNAs (lincRNAs)(5), copies of repeats (6,7), as well as short transcripts in and around transcription start sites (TSSs)(8,9), active enhancers (eRNAs)(10–12) and introns (13).”
BackgroundA transcriptional perspective on human macrophage biology
Schultze, J. L., Freeman, T. C., Hume, D. A., & Latz, E. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.02.001 · Cited by 45
Self-citationDeepEnhancer: Predicting enhancers by convolutional neural networks
Xu, M., Chen, N., Chen, T., & Jiang, R. (2016) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2016.7822593 · Cited by 46
“Note that the permissive enhancers in FANTOM5 are all experimentally verified, while the cell type specific enhancers are predicted results by the ChromHMM model which have lower accuracy.”
MethodInfluentialNanoCAGE: A Method for the Analysis of Coding and Noncoding 5′-Capped Transcriptomes
Poulain, S., Kato, S., Arnaud, O., Morlighem, J.-É. R. L., Suzuki, M., Plessy, C., & Harbers, M. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6716-2_4 · Cited by 39
Prioritization of disease genes from GWAS using ensemble-based positive-unlabeled learning
Kolosov, N., Daly, M. J., & Artomov, M. (2021) · European Journal of Human Genetics · doi:10.1038/s41431-021-00930-w · Cited by 40
Prediction of Enhancers in DNA Sequence Data using a Hybrid CNN-DLSTM Model
Kaur, A., Chauhan, A. P. S., & Aggarwal, A. K. (2022) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2022.3167090 · Cited by 46
“In order to enhance the robustness of the proposed model, the data has been taken from two different datasets viz, FANTOM5 [37] and VISTA Enhancer Browser [38].”
MethodOct4 differentially regulates chromatin opening and enhancer transcription in pluripotent stem cells
Xiong, L., Tolen, E. A., Choi, J., Velychko, S., Caizzi, L., Velychko, T., Adachi, K., MacCarthy, C. M., Lidschreiber, M., Cramer, P., et al. (2022) · eLife · doi:10.7554/elife.71533 · Cited by 42
“The synthesis of eRNA correlates with the transactivation activity of enhancers ( Andersson et al., 2014 ; De Santa et al., 2010 ; Djebali et al., 2012 ; Hah et al., 2013 ; Henriques et al., 2018 ; Kim et al., 2010 ; Melgar et al., 2011 ; Michel et al., 2017 ; Wu et al., 2014 ).”
Developmental enhancers are marked independently of zygotic Nodal signals in Xenopus
Gupta, R., Wills, A. E., Ucar, D., & Baker, J. C. (2014) · Developmental Biology · doi:10.1016/j.ydbio.2014.08.034 · Cited by 44
Towards a Quantitative Understanding of Cell Identity
Ye, Z., & Sarkar, C. A. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.09.002 · Cited by 38
“The FANTOM5 project also published several epigenomic studies, including a human atlas for promoters [15] and enhancers [16].”
Single-cell CRISPR screening in drug resistance
Wang, W. Y., & Wang, X. (2017) · Cell Biology and Toxicology · doi:10.1007/s10565-017-9396-7 · Cited by 38
Active enhancers strengthen insulation by RNA-mediated CTCF binding at chromatin domain boundaries
Islam, Z., Saravanan, B., Walavalkar, K., Thakur, J., Farooq, U., Singh, A. K., Sabarinathan, R., Pandit, A., Henikoff, S., & Notani, D. (2023) · Genome Research · doi:10.1101/gr.276643.122 · Cited by 43
“In general, eRNAs show fast turnover as seen by a higher ratio of nascent-to-mature eRNAs compared with genic RNAs (Andersson et al. 2014).”
BackgroundMethodThe Core Promoter Is a Regulatory Hub for Developmental Gene Expression
Sloutskin, A., Shir-Shapira, H., Freiman, R. N., & Juven‐Gershon, T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.666508 · Cited by 54
Khouri‐Farah, N., Guo, Q., Morgan, K., Shin, J., & Li, J. Y. H. (2022) · Science Advances · doi:10.1126/sciadv.abl9156 · Cited by 42
“6H) ( 37 , 38 ).”
Hecker, D., Ardakani, F. B., Karollus, A., Gagneur, J., & Schulz, M. H. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btad062 · Cited by 51
“Many approaches exist to predict target genes of enhancers, e.g. , using correlation of enhancer activity and gene expression (The FANTOM Consortium et al., 2014; Gao and Qian, 2019; Schmidt et al., 2021), or correlation of accessibility across samples (Pliner et al., 2018).”
BackgroundTranscription factors regulating vasculogenesis and angiogenesis
Payne, S., Neal, A., & Val, S. D. (2023) · Developmental Dynamics · doi:10.1002/dvdy.575 · Cited by 47
McDonagh, E. M., Trynka, G., McCarthy, M. I., Holzinger, E. R., Shameer, K., Nakić, N., Hu, X., Cornu, H., Dunham, I., & Hulcoop, D. G. (2024) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-102523-103838 · Cited by 38
Cis-regulatory somatic mutations and gene-expression alteration in B-cell lymphomas
Mathelier, A., Lefebvre, C., Zhang, A. W., Arenillas, D. J., Ding, J., Wasserman, W. W., & Shah, S. P. (2015) · Genome biology · doi:10.1186/s13059-015-0648-7 · Cited by 42
“Enhancer coordinates were retrieved from [40].”
The genetic and regulatory architecture of ERBB3-type 1 diabetes susceptibility locus
Kaur, S., Mirza, A. H., Brorsson, C., Fløyel, T., Størling, J., Mortensen, H. B., & Pociot, F. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.10.002 · Cited by 43
“Intriguingly, we also found that rs4759229 lies within a known enhancer element (chr12:56474601e56474862) based on FANTOM5 human active enhancer atlas (Andersson et al., 2014).”
Altinel, K., Hashimoto, K., Yu, W., Neuveut, C., Gupta, I., Suzuki, A. M., Santos, A. D., Moreau, P., Xia, T., Kojima, S., et al. (2016) · Journal of Virology · doi:10.1128/jvi.01625-16 · Cited by 48
“CAGE has also shown high reproducibility for expression measurements through a number of large scale projects, including FANTOM (17, 18) and ENCODE (19), discovering novel noncoding RNAs (ncRNAs) and transcribed enhancers (20).”
BackgroundSelf-citationQu, Y., Siggens, L., Cordeddu, L., Gaidzik, V. I., Karlsson, K., Bullinger, L., Döhner, K., Ekwall, K., Lehmann, S., & Lennartsson, A. (2016) · Blood · doi:10.1182/blood-2016-07-726877 · Cited by 42
“Recently, the Functional Annotation of Mammalian Genome (FANTOM) Consortium mapped robust enhancers in the human genomebydetectingenhancer transcriptionusingCAGEtechnology.(18) We used the FANTOMatlas of total CAGE-defined enhancers to study aberrant DNA methylation in enhancer regions in CN-AML cells relative to prog…”
MethodSelf-citationHandoko, L., Kaczkowski, B., Hon, C.-C., Lizio, M., Wakamori, M., Matsuda, T., Ito, T., Jeyamohan, P., Sato, Y., Sakamoto, K., et al. (2018) · Epigenetics · doi:10.1080/15592294.2018.1469891 · Cited by 41
“(e) Enrichment of H4K5acK8ac and other histone marks within FANTOM5-defined enhancer regions.”
MethodKumar, A., Bandapalli, O. R., Paramasivam, N., Giangiobbe, S., Diquigiovanni, C., Bonora, E., Eils, R., Schlesner, M., Hemminki, K., & Försti, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-29952-z · Cited by 38
EPIP: a novel approach for condition-specific enhancer–promoter interaction prediction
Talukder, A., Saadat, S., Li, X., & Hu, H. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz641 · Cited by 37
“Later, several computational approaches were developed based on the correlation of epigenomic signals in enhancers and those in promoters (Corradin et al., 2014; Andersson et al., 2014; Thurman et al., 2012; Ernst et al., 2011).”
MethodJakubosky, D. A., Smith, E. N., D’Antonio, M., Bonder, M. J., Greenwald, W. W. Y., D’Antonio‐Chronowska, A., Matsui, H., Bonder, M. J., Cai, N., Carcamo‐Orive, I., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16481-5 · Cited by 41
A computer-guided design tool to increase the efficiency of cellular conversions
Jung, S., Appleton, E., Ali, M., Church, G. M., & del Sol, A. (2021) · Nature Communications · doi:10.1038/s41467-021-21801-4 · Cited by 38
Pokhilko, A. V., Brezzo, G., Handunnetthi, L., Heilig, R., Lennon, R., Smith, C., Allan, S. M., Granata, A., Sinha, S., Wang, T., et al. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211004307 · Cited by 36
Modeling regulatory network topology improves genome-wide analyses of complex human traits
Zhu, X., Duren, Z., & Wong, W. H. (2021) · Nature Communications · doi:10.1038/s41467-021-22588-0 · Cited by 42
Davis, M. R., Andersson, R., Severin, J., de Hoon, M., Bertin, N., Baillie, J. K., Kawaji, H., Sandelin, A., Forrest, A. R. R., & SUMMERS, K. M. (2013) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.12.006 · Cited by 41
Self-citationDrennan, S., D’Avola, A., Gao, Y., Weigel, C., Chrysostomou, E., Steele, A. J., Zenz, T., Plass, C., Johnson, P., Williams, A. P., et al. (2016) · Leukemia · doi:10.1038/leu.2016.356 · Cited by 39
Enhancer RNAs in transcriptional regulation: recent insights
Chen, Q., Zeng, Y., Kang, J., Hu, M., Li, N., Sun, K., & Zhao, Y. F. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1205540 · Cited by 44
“, eRNAs and enhancer-associated lncRNAs (elncRNAs), appear in the literature to represent transcripts from enhancer regions (Orom et al., 2010; Marques et al., 2013; Andersson et al., 2014; Li et al., 2016; Hon et al., 2017; Statello et al., 2021; Mattick et al., 2023).”
BackgroundAkula, N., Wendland, J. R., Choi, K. H., & McMahon, F. J. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.218 · Cited by 38
“Much of the impact of genetic variation on gene expression is tissuedependent (Andersson et al, 2014).”
BackgroundGray, J. M., Kim, T.-K., West, A. E., Nord, A. S., Markenscoff-Papadimitriou, E., & Lomvardas, S. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2622-15.2015 · Cited by 36
Chromatin remodeling effects on enhancer activity
García-González, E. G., Escamilla-Del-Arenal, M., Arzate‐Mejía, R. G., & Targa, F. R. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2184-3 · Cited by 48
Nuclear Compartments, Genome Folding, and Enhancer-Promoter Communication
Ulianov, S. V., Gavrilov, A. A., & Razin, S. V. (2015) · International review of cytology · doi:10.1016/bs.ircmb.2014.11.004 · Cited by 40
On the Regulatory Evolution of New Genes Throughout Their Life History
Zhang, J., & Zhou, Q. (2018) · Molecular Biology and Evolution · doi:10.1093/molbev/msy206 · Cited by 40
Spracklen, C. N., Shi, J., Vadlamudi, S., Wu, Y., Zou, M., Raulerson, C. K., Davis, J. P., Zeynalzadeh, M., Jackson, K. C., Yuan, W., et al. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007275 · Cited by 37
Wu, C., & Pan, W. (2018) · Genetics · doi:10.1534/genetics.118.300805 · Cited by 38
“Second, we defined two promoter regions of a gene by extending 500 bp (Andersson et al. 2014) upstream (from its TSS) or downstream (from its TES) of the gene.”
BackgroundEpigenetic plasticity of enhancers in cancer
Yao, J., Chen, J., Li, L., & Wu, M. (2020) · Transcription · doi:10.1080/21541264.2020.1713682 · Cited by 40
Neyton, L. P. A., Zheng, X., Skouras, C., Doeschl‐Wilson, A., Gutmann, M. U., Yau, C., Uings, I., Rao, F. V., Nicolas, A., Marshall, C., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003974 · Cited by 37
“Disease endotyping Disease endotypes have been commonly described using one data type, in sepsis for example(12, 13, 15).”
BackgroundMethodInfluentialSelf-citationAbiotic stress-mediated modulation of the chromatin landscape in Arabidopsis thaliana
Raxwal, V. K., Ghosh, S., Singh, S., Katiyar‐Agarwal, S., Goel, S., Jagannath, A., Kumar, A., Scaria, V., & Agarwal, M. (2020) · Journal of Experimental Botany · doi:10.1093/jxb/eraa286 · Cited by 35
Qin, N., Li, Y., Wang, C., Zhu, M., Dai, J., Hong, T., Albanes, D., Lam, S. C., Tardón, A., Chen, C., et al. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0779-4 · Cited by 36
Revisiting 3D chromatin architecture in cancer development and progression
Feng, Y., & Pauklin, S. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa747 · Cited by 38
“Due to their short half-lives compared to mRNA and lncRNAs (55), annotations of eRNAs depend on nascent RNA sequencing approaches, such as Cap Analysis of Gene Expression (CAGE) (56,57)/native elongating transcript–cap analysis of gene expression (NET-CAGE) (58), Global RunOn Sequencing (GRO-Seq) (59) or its refinemen…”
BackgroundERα in the Control of Mitochondrial Function and Metabolic Health
Hevener, A. L., Ribas, V., Moore, T. M., & Zhou, Z. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.09.006 · Cited by 39
DeepCAPE: A Deep Convolutional Neural Network for the Accurate Prediction of Enhancers
Chen, S., Gan, M., Lv, H., & Jiang, R. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2019.04.006 · Cited by 38
“Besides, using a technique called Cap Analysis of Gene Expression (CAGE), the FANTOM project [9] has mapped promoters and enhancers that are active in mammalian primary cell lines [10].”
MethodFunctional mapping of androgen receptor enhancer activity
Huang, C.-C. F., Lingadahalli, S., Morova, T., Özturan, D., Hu, E., Yu, I. P. L., Linder, S., Hoogstraat, M., Stelloo, S., Sar, F., et al. (2021) · Genome biology · doi:10.1186/s13059-021-02339-6 · Cited by 41
Retinoids in the Pathogenesis and Treatment of Liver Diseases
Melis, M., Tang, X., Trasino, S. E., & Gudas, L. J. (2022) · Nutrients · doi:10.3390/nu14071456 · Cited by 40
“sequences that increase transcription independently of their distance from a promoter [12].”
BackgroundDeforzh, E., Uhlmann, E. J., Das, E., Galitsyna, A. A., Arora, R., Saravanan, H., Rabinovsky, R., Wirawan, A., Teplyuk, N. M., Fatimy, R. E., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.03.018 · Cited by 38
BET bromodomain inhibitors in leukemia
Basheer, F., & Huntly, B. J. P. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.06.004 · Cited by 41
“Through further ChIP-seq combined studies that included the enhancer mark H3K27Ac to catalogue superenhancer presence, another 86 normal tissue types and cancer cell lines were analyzed [34].”
BackgroundMethodUnravelling the molecular basis for regulatory T‐cell plasticity and loss of function in disease
Sadlon, T. J., Brown, C. Y., Bandara, V., Hope, C. M., Schjenken, J. E., Pederson, S., Breen, J., Forrest, A. R. R., Beyer, M., Robertson, S. A., et al. (2018) · Clinical & Translational Immunology · doi:10.1002/cti2.1011 · Cited by 42
“Localised patterns of chromatin modification, such as DNA methylation, histone modification and nucleosome remodelling, correlate with enhancer activity, transcription factor binding and initiation or repression of transcription.(99,109,110) More recently, these approaches have enabled the identification of a rare sub…”
BackgroundSelf-citationRole of epigenetics in the development of childhood asthma
Davidson, E., & Yang, I. V. (2018) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000429 · Cited by 37
“Large-scale data from international consortia (ENCODE [7], FANTOM5 [8], and Roadmap Epigenomics [9]) have identified enhancers as critical regions involved in regulation of gene expression”
Linking diabetic vascular complications with LncRNAs
Leung, A., Samara, V. A., & Natarajan, R. D. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.01.007 · Cited by 37
chromstaR: Tracking combinatorial chromatin state dynamics in space and timePreprint
Taudt, A., Nguyen, M. A., Heinig, M., Johannes, F. M., & Colomé‐Tatché, M. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/038612 · Cited by 36
Yan, B., Tzertzinis, G., Schildkraut, I., & Ettwiller, L. M. (2021) · Genome Research · doi:10.1101/gr.275784.121 · Cited by 37
“Enhancers that were located distant to first exons (>500 bp) and to other exons (>200 bp) (Andersson et al. 2014; Gao and Qian 2020) in UCSC annotation were overlapped with the Pol II and non–Pol II TSS data sets.”
MethodWang, J., Dayem Ullah, A. Z., & Chelala, C. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky057 · Cited by 35
“(4) Weight estimation via eigendecomposition: the estimated weights for the individual scoring systems were calculated using the eigendecomposition of the covariance matrix.”
BackgroundMethodKunkle, B., Grenier-Boley, B., Sims, R., Bis, J., Naj, A., Boland, A., Vronskaya, M., van der Lee, S., Amlie-Wolf, A., Bellenguez, C., et al. (2018) · doi:10.1101/294629 · Cited by 35
Self-citationCritical roles of super-enhancers in the pathogenesis of autoimmune diseases
Yamagata, K., Nakayamada, S., & Tanaka, Y. (2020) · Inflammation and Regeneration · doi:10.1186/s41232-020-00124-9 · Cited by 32
Archuleta, S. R., Goodrich, J. A., & Kugel, J. F. (2024) · Biomolecules · doi:10.3390/biom14020176 · Cited by 44
“Signals of bidirectional transcription at enhancers indicate their active influence in gene expression [102,103].”
BackgroundNuclear RNA homeostasis promotes systems-level coordination of cell fate and senescence
Han, X., Xing, L., Hong, Y., Zhang, X., Hao, B., Lu, J. Y., Huang, M., Wang, Z., Ma, S., Zhan, G., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.03.015 · Cited by 42
Simon, M., Stüve, P., Schmidleithner, L., Bittner, S., Beumer, N., Strieder, N., Schmidl, C., Pant, A., Gebhard, C., Eigenberger, A., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.06.015 · Cited by 39
Self-citationSiCLAT: simultaneous imaging of chromatin loops and active transcription in living cells
Wan, X., Kong, J., Hu, X., Liu, L., Yang, Y., Li, H., Liu, G., Niu, X., Chen, F., Zhang, D., et al. (2025) · Genome biology · doi:10.1186/s13059-024-03463-9 · Cited by 45
Sex-stratified genome-wide association meta-analysis of major depressive disorder
Thomas, J. T., Thorp, J. G., Huider, F., Grimes, P. Z., Wang, R., Youssef, P., Coleman, J. R. I., Byrne, E. M., Adams, M. J., van Loo, H. M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63236-1 · Cited by 45
Exploiting genomics and natural genetic variation to decode macrophage enhancers
Romanoski, C. E., Link, V. M., Heinz, S., & Glass, C. K. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.07.006 · Cited by 35
“Limitations to systematic mutagenesis have been greatly reduced by the development of CRISPR/Cas9- and TALEN-based methods, which will be a mainstay in interrogating enhancer function going forward [28].”
MethodRelationships between PROMPT and gene expression
Lloret-Llinares, M., Mapendano, C. K., Martlev, L. H., Lykke‐Andersen, S., & Jensen, T. H. (2015) · RNA Biology · doi:10.1080/15476286.2015.1109769 · Cited by 40
Self-citationLennartsson, A., Arner, E., Fagiolini, M., Saxena, A., Andersson, R., Takahashi, H., Noro, Y., Sng, J., Sandelin, A., Hensch, T. K., et al. (2015) · Epigenetics & Chromatin · doi:10.1186/s13072-015-0043-3 · Cited by 34
“Recently, this was used to map active enhancers in the FANTOM5 panel of tissues and primary cell types [38].”
BackgroundMethodSelf-citationThe origins of developmental gene regulation
Arenas‐Mena, C. (2017) · Evolution & Development · doi:10.1111/ede.12217 · Cited by 35
SUMMERS, K. M., & Hume, D. A. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.1a0417-150rr · Cited by 35
“The browser also shows the location of active enhancers, detected based on bidirectional promoter activity [37].”
BackgroundSelf-citationEnhancer reprogramming in tumor progression: a new route towards cancer cell plasticity
Fagnocchi, L., Poli, V., & Zippo, A. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2820-1 · Cited by 40
Probing transcription factor combinatorics in different promoter classes and in enhancers
Vandel, J., Cassan, O., Lèbre, S., Lecellier, C., & Bréhélin, L. (2019) · BMC Genomics · doi:10.1186/s12864-018-5408-0 · Cited by 41
“Furthermore, as promoters and enhancers produce different RNAmolecules [49, 21], our results also suggest that the production of enhancer RNAs (eRNAs) on one hand, and that of mRNAs, lncRNAs, andmiRNAs on the other hand, requires a specific and distinct subset of TFs.”
InfluentialLarsson, C., Cordeddu, L., Siggens, L., Pandzic, T., Kundu, S., He, L., Ali, M. A., Pristovšek, N., Hartman, K., Ekwall, K., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00863-z · Cited by 35
Pignarre, A., Chatonnet, F., Caron, G., Haas, M., Desmots, F., & Fest, T. (2020) · Blood · doi:10.1182/blood.2020005083 · Cited by 39
Intergenic RNA mainly derives from nascent transcripts of known genes
Agostini, F., Zagalak, J. A., Attig, J., Ule, J., & Luscombe, N. M. (2021) · Genome biology · doi:10.1186/s13059-021-02350-x · Cited by 36
“collection of cell lines and tissues [40, 41].”
Yang, R., Quan, J., Sodaei, R., Aguet, F., Segrè, A. V., Allen, J., Lanz, T. A., Reinhart, V., Crawford, M. E., Hasson, S. A., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/311563 · Cited by 41
Detection of ovarian cancer using plasma cell-free DNA methylomes
Lu, H., Liu, Y., Wang, J., Fu, S., Wang, L., Huang, C., Li, J., Xie, L., Wang, D., Li, D., et al. (2022) · Clinical Epigenetics · doi:10.1186/s13148-022-01285-9 · Cited by 39
“classification Data from cfMeDIP-seq profiles were first reduced to map functional regions including CpG islands, shores, shelves, FANTOM5 human enhancers, and promoters as previously described [29, 30].”
MethodMiheecheva, N., Postovalova, E., Lyu, Y., Ramachandran, A., Bagaev, A., Svekolkin, V., Galkin, I., Zyrin, V., Maximov, V., Lozinsky, Y., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111180 · Cited by 38
An atlas of transcribed enhancers across helper T cell diversity for decoding human diseases
Oguchi, A., Suzuki, A., Komatsu, S., Yoshitomi, H., Bhagat, S., Son, R., Bonnal, R. J. P., Kojima, S., Koido, M., Takeuchi, K., et al. (2024) · Science · doi:10.1126/science.add8394 · Cited by 42
“Enhancers with bidirectional eRNAs are more functional than untranscribed ones ( 3 , 11 , 19 , 20 ).”
BackgroundResultInfluentialSelf-citationIdentification of differentially methylated regions in new genes associated with knee osteoarthritis
Bonin, C. A., Lewallen, E. A., Baheti, S., Bradley, E. W., Stuart, M. J., Berry, D. J., van Wijnen, A. J., & Westendorf, J. J. (2015) · Gene · doi:10.1016/j.gene.2015.10.037 · Cited by 35
“However, this information can only be productively harnessed after detailed mapping of distal regulatory elements is completed [33].”
BackgroundlncRNA and gene looping: what’s the connection?
Shibayama, Y., Fanucchi, S., Magagula, L., & Mhlanga, M. M. (2014) · Transcription · doi:10.4161/trns.28658 · Cited by 43
“A remarkable recent observation is the bi-directional transcription of a novel class of lncRNA termed enhancer RNA (eRNA), also known as activating RNA,(13,14) arising from enhancer loci throughout the genome.(15,16) Stimulus-dependent transcription of eRNA has been correlated with transcriptional activation of nearby…”
BackgroundWidespread genome transcription: New possibilities for RNA therapies
Takahashi, H., & Carninci, P. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.139 · Cited by 35
“To further complicate the interpretation and analysis of lncRNAs, active enhancers also produce lncRNAs, often called eRNAs [6,13], whose function is mostly unknown.”
BackgroundSelf-citationEhrlund, A., Mejhert, N., Björk, C., Andersson, R., Kulyté, A., Åström, G., Itoh, M., Kawaji, H., Lassmann, T., Daub, C. O., et al. (2016) · Diabetes · doi:10.2337/db16-0631 · Cited by 40
“3B) with previously identified enhancers from commercially available PreAds, adipocytes, and adipose tissue (23).”
InfluentialSelf-citationIenasescu, H., Li, K., Andersson, R., Vitezic, M., Rennie, S., Chen, Y., Vitting‐Seerup, K., Lagoni, E., Boyd, M., Bornholdt, J., et al. (2016) · Database · doi:10.1093/database/baw144 · Cited by 34
“The atlas measures enhancer RNA expression across cells and tissues, which is a proxy for enhancer activity (9).”
BackgroundMethodInfluentialSelf-citationJurj, A. M., Pop, L., Petrushev, B., Paşca, S., Dima, D. M., Frinc, I., Deak, D., Desmirean, M., Trifa, A. P., Fetică, B., et al. (2018) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2018.1499707 · Cited by 37
Gulko, B., & Siepel, A. C. (2018) · Nature Genetics · doi:10.1038/s41588-018-0300-z · Cited by 35
Nuclear AGO1 Regulates Gene Expression by Affecting Chromatin Architecture in Human Cells
Shuaib, M., Parsi, K. M., Thimma, M., Adroub, S. A., Kawaji, H., Seridi, L., Ghosheh, Y., Fort, A., Fallatah, B., Ravasi, T., et al. (2019) · Cell Systems · doi:10.1016/j.cels.2019.09.005 · Cited by 34
“The putative active enhancers are marked by bidirectional transcription of nuclear enhancer RNAs (eRNAs) that can be detected by CAGE (Andersson et al., 2014).”
BackgroundSelf-citationKorecki, A. J., Vargas, J. L. C., Fornés, O., Agostinone, J., Farkas, R. A., Hickmott, J. W., Lam, S. L., Mathelier, A., Zhou, M., Wasserman, W. W., et al. (2021) · Gene Therapy · doi:10.1038/s41434-021-00227-z · Cited by 36
“RRs were classified into promoters (regions overlapping a transcription start site, as indicated by CAGE data) or enhancers, and the most promising regions were placed into MiniPromoter constructs.”
BackgroundMethodInfluentialRunx1 shapes the chromatin landscape via a cascade of direct and indirect targets
Hass, M. R., Brissette, D., Parameswaran, S., Pujato, M. A., Donmez, O., Kottyan, L. C., Weirauch, M. T., & Kopan, R. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009574 · Cited by 34
Animal-eRNAdb: a comprehensive animal enhancer RNA database
Jin, W., Jiang, G., Yang, Y., Yang, J., Yang, W., Wang, D., Niu, X., Zhong, R., Zhang, Z., & Gong, J. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab832 · Cited by 47
“Ander-sson et al . systematically annotated ∼ 65 000 eRNAs by the FANTOM project in ∼ 400 human tissues and cell types us-ing the cap analysis of gene expression (CAGE-seq) technique targeting the molecules with 5’cap (17).”
Beyond GWAS: from simple associations to functional insights
Ishigaki, K. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00894-5 · Cited by 37
Transcriptional Enhancers: Bridging the Genome and Phenome
Ren, B., & Yue, F. (2015) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2015.80.027219 · Cited by 34
Natri, H. M., Hudjashov, G., Jacobs, G., Kusuma, P., Saag, L., Darusallam, C. C., Metspalu, M., Sudoyo, H., Cox, M. P., Gallego Romero, I., et al. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.11.017 · Cited by 33
“16.1 (web resources), and enhancer annotations from FANTOM5.”
MethodInfluentialRapid and Scalable Profiling of Nascent RNA with fastGRO
Barbieri, E., Hill, C., Quesnel-Vallières, M., Zucco, A. J., Barash, Y., & Gardini, A. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108373 · Cited by 33
“Additionally, eRNAs have been used to gauge enhancer activity throughout development and were shown to directly impact gene expression (Andersson et al., 2014; Lai et al., 2015; Bose et al., 2017).”
Greenfest‐Allen, E., Valladares, O., Kuksa, P. P., Gangadharan, P., Lee, W., Cifello, J., Katanić, Ž., Kuzma, A. B., Wheeler, N. R., Bush, W. S., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13509 · Cited by 34
A chromatin-regulated biphasic circuit coordinates IL-1β-mediated inflammation
Fok, E. T., Moorlag, S. J. C. F. M., Negishi, Y., Groh, L. A., dos Santos, J. C., Gräwe, C., Monge, V. V., Craenmehr, D. D. D., van Roosmalen, M., Jolvino, D. P. D. C., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01598-2 · Cited by 41
“Enhancer regions are often transcribed into eRNAs which collaborate with the Mediator complex to mediate long-range chromosomal contacts 29–31, 49, 50 .”
Self-citationSchil, K. V., Karlstetter, M., Aslanidis, A., Dannhausen, K., Azam, M., Qamar, R., Leroy, B. P., Depasse, F., Langmann, T., & Baere, E. B. W. D. (2016) · Scientific Reports · doi:10.1038/srep21307 · Cited by 42
Identification and function of enhancers in the human genome
Coppola, C. J., Ramaker, R. C., & Mendenhall, E. M. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw216 · Cited by 39
“eRNA transcription has been indicated as a strong marker of enhancer activity by large scale reporter assays suggesting that putative enhancers harbouring higher levels of eRNA transcription are significantly more likely to show reporter activity (57).”
BackgroundNew era in genetics of early-onset muscle disease: Breakthroughs and challenges
Ravenscroft, G., Davis, M. R., Lamont, P. J., Forrest, A. R. R., & Laing, N. G. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.08.002 · Cited by 31
Self-citationChromatin structure–based prediction of recurrent noncoding mutations in cancer
Kim, K., Jang, K., Yang, W., Choi, E.-Y., Park, S.-M., Bae, M., Kim, Y., & Choi, J. K. (2016) · Nature Genetics · doi:10.1038/ng.3682 · Cited by 36
Metadata
- Authors
- The FANTOM Consortium, Andersson, R., Gebhard, C., Miguel-Escalada, I., Hoof, I., Bornholdt, J., Boyd, M., Chen, Y., Zhao, X., Schmidl, C., Suzuki, T., Ntini, E., Arner, E., Valen, E., Li, K., Schwarzfischer, L., Glatz, D., Raithel, J., Lilje, B., Rapin, N., Bagger, F. O., Jørgensen, M., Andersen, P. R., Bertin, N., Rackham, O., Burroughs, A. M., Baillie, J. K., Ishizu, Y., Shimizu, Y., Furuhata, E., Maeda, S., Negishi, Y., Mungall, C. J., Meehan, T. F., Lassmann, T., Itoh, M., Kawaji, H., Kondo, N., Kawai, J., Lennartsson, A., Daub, C. O., Heutink, P., Hume, D. A., Jensen, T. H., Suzuki, H., Hayashizaki, Y., Müller, F., Forrest, A. R. R., Carninci, P., Rehli, M., & Sandelin, A.
- Affiliations
- University of Copenhagen (DK)
- University Hospital Regensburg (DE)
- University of Birmingham (GB)
- University of North Carolina at Chapel Hill (US)
- RIKEN (JP)
- Aarhus University (DK)
- Roslin Institute (GB)
- European Bioinformatics Institute (GB)
- Karolinska Institutet (SE)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Corresponding author
- Forrest, Alistair R. R.
- Carninci, Piero
- Rehli, Michael
- Sandelin, Albin
- ORCID
- Andersson, Robin
- Gebhard, Claudia
- Miguel-Escalada, Irene
- Hoof, Ilka
- Bornholdt, Jette
- Chen, Yun
- Schmidl, Christian
- Suzuki, Takahiro
- Ntini, Evgenia
- Valen, Eivind
- Li, Kang
- Lilje, Berit
- Rapin, Nicolas
- Bagger, Frederik Otzen
- Andersen, Peter Refsing
- Bertin, Nicolas
- Rackham, Owen
- Burroughs, A. Maxwell
- Baillie, J. Kenneth
- Ishizu, Yuri
- Shimizu, Yuri
- Furuhata, Erina
- Meehan, Terrence F.
- Lassmann, Timo
- Itoh, Masayoshi
- Kawaji, Hideya
- Kawai, Jun
- Lennartsson, Andreas
- Daub, Carsten O.
- Heutink, Peter
- Hume, David A.
- Jensen, Torben Heick
- Suzuki, Harukazu
- Hayashizaki, Yoshihide
- Müller, Ferenc
- Forrest, Alistair R. R.
- Carninci, Piero
- Rehli, Michael
- Sandelin, Albin
- Venue
- Nature
- Published
- 2014-03
- Volume
- 507
- Issue
- 7493
- Pages
- 455-461
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5215096
- OpenAlex
- W2015845481
- Cited by
- 2,550
- References
- 81
- Citations by year
- 2026: 93 · 2025: 140 · 2024: 207 · 2023: 185 · 2022: 225 · 2021: 280 · 2020: 232 · 2019: 226 · 2018: 261 · 2017: 208 · 2016: 186 · 2015: 212 · 2014: 89
- FWCI
- 95.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion)
- PubMed Central (acceptedVersion)
- SDL (submittedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Griffith Research Online (submittedVersion)
- Funders
- Wellcome Trust (103258/Z/13/Z)
- European Commission (FP7/2007–2013/ERC, 2007–2013, FP7 2007-2013, FP7/2007)
- Deutsche Forschungsgemeinschaft (FP7/2007–2013)
- Ministry of Education, Culture, Sports, Science and Technology
- Lundbeckfonden (R167-2013-15058, R82-2010-6779)
- Novo Nordisk
- Novo Nordisk Fonden (NNF12OC0001211)
- H. Lundbeck A/S
- Biotechnology and Biological Sciences Research Council (BBS/E/D/20251969, BB/I024801/1)
- Japan Society for the Promotion of Science (24659373, 25330333, 22228005)
- RIKEN
- National Institute of Dental and Craniofacial Research (R01DE022969)
- FP7 Ideas: European Research Council (204135)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Keywords
- enhancers, bidirectional transcription, unspliced RNA, FANTOM5, CAGE, cell type-specific gene regulation, regulatory single nucleotide polymorphisms, enhancer redundancy, transcription start sites, promoter usage, human cell types, tissue-specific enhancers
- MeSH terms
- Atlases as Topic, Cell Line, Cells, Cultured, Enhancer Elements, Genetic, Gene Expression Regulation, HeLa Cells, Humans, Organ Specificity, Promoter Regions, Genetic, RNA, Messenger, Cluster Analysis, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Transcription Initiation Site, Molecular Sequence Annotation, Transcription Initiation, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.